The genetics of human systemic lupus erythematosus

Trends in Immunology

Volumn 24, Issue 11, 2003, Pages 595-602

  Tsao, Betty P ^a  

^a UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

DIPEPTIDYL CARBOXYPEPTIDASE;

CLINICAL PROTOCOL; DISEASE PREDISPOSITION; GENE MAPPING; GENETIC HETEROGENEITY; GENETIC LINKAGE; GENETIC PREDISPOSITION; GENETIC SUSCEPTIBILITY; GENETIC TRAIT; HUMAN; HUMAN GENOME; MAJOR HISTOCOMPATIBILITY COMPLEX; PREGNANCY; REVIEW; SYSTEMIC LUPUS ERYTHEMATOSUS;

EID: 0242302583     PISSN: 14714906     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.it.2003.09.006     Document Type: Review

References (64)

1. Tan E.M., et al. Special article: The 1982 revised criteria for the classification of SLE. Arthritis Rheum. 25:1982;1271-1277.
2. Hochberg M.C. Updating the American college of rheumatology revised criteria for the classification of systemic lupus erythematosus. Arthritis Rheum. 40:1997;1725-1734.
3. Hochberg M.C. The epidemiology of systemic lupus erythematosus. Wallace D.J., Hahn B.H. Dubois' Lupus Erythematosus. 1997;49-65 Williams and Wilkins.
4. Wanstrat A., Wakeland E. The genetics of complex autoimmune diseases: non-MHC susceptibility genes. Nat. Immunol. 2:2001;802-809.
5. Wakeland E.K., et al. Delineating the genetic basis of systemic lupus erythematosus. Immunity. 15:2001;397-408.
6. Lander E.S., Schork N.J. Genetic dissection of complex traits. Science. 265:1994;2037-2048.
7. Lander E.S., Kruglyak L. Genetic dissection of complex traits: guidelines for interpreting and reporting linkage results. Nat. Genet. 11:1995;241-247.
8. Tsao B.P., et al. Evidence for linkage of a candidate chromosome 1 region to human systemic lupus erythematosus. J. Clin. Invest. 99:1997;725-731.
9. Gaffney P.M., et al. A genome-wide search for susceptibility genes in human systemic lupus erythematosus sib-pair families. Proc. Natl. Acad. Sci. U. S. A. 95:1998;14875-14879.
10. Moser K.L., et al. Genome scan of human systemic lupus erythematosus: evidence for linkage on chromosome 1q in African-American pedigrees. Proc. Natl. Acad. Sci. U. S. A. 95:1998;14869-14874.
11. Gaffney P.M., et al. Genome screening in human systemic lupus erythematosus: results from a second Minnesota cohort and combined analyses of 187 sib-pair families. Am. J. Hum. Genet. 66:2000;547-556.
12. Gray-McGuire C., et al. Genome scan of human systemic lupus erythematosus by regression modeling: evidence of linkage and epistasis at 4p16-15.2. Am. J. Hum. Genet. 67:2000;1460-1469.
13. Lindqvist A.K., et al. A susceptibility locus for human systemic lupus erythematosus (hSLE1) on chromosome 2q. J. Autoimmun. 14:2000;169-178.
14. Shai R., et al. Genome-wide screen for systemic lupus erythematosus susceptibility genes in multiplex families. Hum. Mol. Genet. 8:1999;639-644.
15. Tsao B.P., et al. PARP alleles within the linked chromosomal region are associated with systemic lupus erythematosus. J. Clin. Invest. 103:1999;1135-1140.
16. Moser K.L., et al. Confirmation of genetic linkage between human systemic lupus erythematosus and chromosome 1q41. Arthritis Rheum. 42:1999;1902-1907.
17. Graham R.R., et al. Genetic linkage and transmission disequilibrium of marker haplotypes at chromosome 1q41 in human systemic lupus erythematosus. Arthritis Res. 3:2001;299-305.
18. Magnusson V., et al. Fine mapping of the SLEB2 locus involved in susceptibility to systemic lupus erythematosus. Genomics. 70:2000;307-314.
19. Johanneson B., et al. A major susceptibility locus for systemic lupus erythemathosus maps to chromosome 1q31. Am. J. Hum. Genet. 71:2002;1060-1071.
20. Zuniga R., et al. Identification of IgG subclasses and C-reactive protein in lupus nephritis: the relationship between the composition of immune deposits and FCγ receptor type IIA alleles. Arthritis Rheum. 48:2003;460-470.
21. Kelly J.A., et al. Evidence for a susceptibility gene (SLEH1) on chromosome 11q14 for systemic lupus erythematosus (SLE) families with hemolytic anemia. Proc. Natl. Acad. Sci. U. S. A. 99:2002;11766-11771.
22. Namjou B., et al. Genome scan stratified by the presence of anti-double-stranded DNA (dsDNA) autoantibody in pedigrees multiplex for systemic lupus erythematosus (SLE) establishes linkages at 19p13.2 (SLED1) and 18q21.1 (SLED2). Genes Immun. 3:(Suppl 1):2002;S35-S41.
23. Namjou B., et al. Stratification of pedigrees multiplex for systemic lupus erythematosus and for self-reported rheumatoid arthritis detects a systemic lupus erythematosus susceptibility gene (SLER1) at 5p15.3. Arthritis Rheum. 46:2002;2937-2945.
24. Nath S.K., et al. Evidence for a susceptibility gene, SLEV1, on chromosome 17p13 in families with vitiligo-related systemic lupus erythematosus. Am. J. Hum. Genet. 69:2001;1401-1406.
25. Nath S.K., et al. SLEB3 in systemic lupus erythematosus (SLE) is strongly related to SLE families ascertained through neuropsychiatric manifestations. Hum. Genet. 111:2002;54-58.
26. Quintero-Del-Rio A.I., et al. The genetics of systemic lupus erythematosus stratified by renal disease: linkage at 10q22.3 (SLEN1), 2q34-35 (SLEN2), and 11p15.6 (SLEN3). Genes Immun. 3:(Suppl 1):2002;S57-S62.
27. Scofield R.H., et al. Thrombocytopenia identifies a severe familial phenotype of systemic lupus erythematosus and reveals genetic linkages at 1q22 and 11p13. Blood. 101:2003;992-997.
28. Sawalha A.H., et al. Genetic linkage of systemic lupus erythematosus with chromosome 11q14 (SLEH1) in African-American families stratified by a nucleolar antinuclear antibody pattern. Genes Immun. 3:(Suppl 1):2002;S31-S34.
29. Rao S., et al. Linkage analysis of human systemic lupus erythematosus-related traits: a principal component approach. Arthritis Rheum. 44:2001;2807-2818.
30. Olson J.M., et al. A genome screen of systemic lupus erythematosus using affected-relative- pair linkage analysis with covariates demonstrates genetic heterogeneity. Genes Immun. 3:(Suppl 1):2002;S5-S12.
31. Tsao B.P., et al. Familiality and co-occurrence of clinical features of systemic lupus erythematosus. Arthritis Rheum. 46:2002;2678-2685.
32. Spielman R.S., et al. Transmission test for linkage disequilibrium: the insulin gene region and insulin-dependent diabetes mellitus (IDDM). Am. J. Hum. Genet. 52:1993;506-516.
33. Graham R.R., et al. Visualizing human leukocyte antigen class II risk haplotypes in human systemic lupus erythematosus. Am. J. Hum. Genet. 71:2002;543-553.
34. Tsuchiya N., et al. Analysis of the association of HLA-DRB1, TNFα promoter and TNFR2 (TNFRSF1B) polymorphisms with SLE using transmission disequilibrium test. Genes Immun. 2:2001;317-322.
35. Hugot J.P., et al. Association of NOD2 leucine-rich repeat variants with susceptibility to Crohn's disease. Nature. 411:2001;599-603.
36. Lesage S., et al. CARD15/NOD2 mutational analysis and genotype-phenotype correlation in 612 patients with inflammatory bowel disease. Am. J. Hum. Genet. 70:2002;845-857.
37. Chamaillard M., et al. Gene-environment interaction modulated by allelic heterogeneity in inflammatory diseases. Proc. Natl. Acad. Sci. U. S. A. 100:2003;3455-3460.
38. Tsao B.P. The genetics of human lupus. Wallace D.J., Hahn B.H. Dubois' Lupus Erythematosus. 2002;97-120 Lippincott Williams & Wilkins.
39. Pickering M.C., Walport M.J. Links between complement abnormalities and systemic lupus erythematosus. Rheumatology (Oxford). 39:2000;133-141.
40. Botto M., et al. Homozygous C1q deficiency causes glomerulonephritis associated with multiple apoptotic bodies. Nat. Genet. 19:1998;56-59.
41. Mitchell D.A., et al. C1q deficiency and autoimmunity: the effects of genetic background on disease expression. J. Immunol. 168:2002;2538-2543.
42. Blanchong C.A., et al. Genetic, structural and functional diversities of human complement components C4A and C4B and their mouse homologues, Slp and C4. Int. Immunopharmacol. 1:2001;365-392.
43. Chen Z., et al. Complement C4 inhibits systemic autoimmunity through a mechanism independent of complement receptors CR1 and CR2. J. Exp. Med. 192:2000;1339-1352.
44. Einav S., et al. Complement C4 is protective for lupus disease independent of C3. J. Immunol. 168:2002;1036-1041.
45. Salmon J.E., Pricop L. Human receptors for immunoglobulin G: key elements in the pathogenesis of rheumatic disease. Arthritis Rheum. 44:2001;739-750.
46. Karassa F.B., et al. Role of the Fcγ receptor IIa polymorphism in susceptibility to systemic lupus erythematosus and lupus nephritis: a meta-analysis. Arthritis Rheum. 46:2002;1563-1571.
47. Stein M.P., et al. C-reactive protein binding to FcγRIIa on human monocytes and neutrophils is allele-specific. J. Clin. Invest. 105:2000;369-376.
48. Karassa F.B., et al. The Fcγ RIIIA-F158 allele is a risk factor for the development of lupus nephritis: a meta-analysis. Kidney Int. 63:2003;1475-1482.
49. Kyogoku C., et al. Fcγ receptor gene polymorphisms in Japanese patients with systemic lupus erythematosus: contribution of FCGR2B to genetic susceptibility. Arthritis Rheum. 46:2002;1242-1254.
50. Nishimura H., Honjo T. PD-1: an inhibitory immunoreceptor involved in peripheral tolerance. Trends Immunol. 22:2001;265-268.
51. Nishimura H., et al. Development of lupus-like autoimmune diseases by disruption of the PD-1 gene encoding an ITIM motif-carrying immunoreceptor. Immunity. 11:1999;141-151.
52. Nishimura H., et al. Autoimmune dilated cardiomyopathy in PD-1 receptor-deficient mice. Science. 291:2001;319-322.
53. Prokunina L., et al. A regulatory polymorphism in PDCD1 is associated with susceptibility to systemic lupus erythematosus in humans. Nat. Genet. 32:2002;666-669.
54. Oliver F.J., et al. Poly(ADP-ribose) polymerase in the cellular response to DNA damage, apoptosis, and disease. Am. J. Hum. Genet. 64:1999;1282-1288.
55. Decker P., et al. Zinc is an essential cofactor for recognition of the DNA binding domain of poly(ADP-ribose) polymerase by antibodies in autoimmune rheumatic and bowel diseases. Arthritis Rheum. 41:1998;918-926.
56. Decker P., et al. Inhibition of caspase-3-mediated poly(ADP-ribose) polymerase (PARP) apoptotic cleavage by human PARP autoantibodies and effect on cells undergoing apoptosis. J. Biol. Chem. 275:2000;9043-9046.
57. Tsao B.P. Lupus susceptibility genes on human chromosome 1. Int. Rev. Immunol. 19:2000;319-334.
58. Oei S.L., Shi Y. Poly(ADP-ribosyl)ation of transcription factor Yin Yang 1 under conditions of DNA damage. Biochem. Biophys. Res. Commun. 285:2001;27-31.
59. Criswell L.A., et al. PARP alleles and SLE: failure to confirm association with disease susceptibility. J. Clin. Invest. 105:2000;1501-1502.
60. Delrieu O., et al. Poly(ADP-ribose) polymerase alleles in French Caucasians are associated neither with lupus nor with primary antiphospholipid syndrome. GRAID Research Group. Group for Research on Auto-Immune Disorders. Arthritis Rheum. 42:1999;2194-2197.
61. Boorboor P., et al. Poly(ADP-ribose) polymerase polymorphisms are not a genetic risk factor for systemic lupus erythematosus in German Caucasians. J. Rheumatol. 27:2000;2061.
62. Tan F.K., et al. Poly(ADP)-ribose polymerase and susceptibility to systemic lupus erythematosus and primary antiphospholipid syndrome: comment on the article by Delrieu et al. [letter]. Arthritis Rheum. 43:2000;1421-1423.
63. Pascual M., et al. A poly(ADP-ribose) polymerase haplotype spanning the promoter region confers susceptibility to rheumatoid arthritis. Arthritis Rheum. 48:2003;638-641.
64. Parsa A., et al. Association of angiotensin-converting enzyme polymorphisms with systemic lupus erythematosus and nephritis: analysis of 644 SLE families. Genes Immun. 3:(Suppl 1):2002;S42-S46.